財(cai)政部(bu)(bu)網站2日消息,國家衛計(ji)委、財(cai)政部(bu)(bu)等七部(bu)(bu)門近日下發關于全(quan)面(mian)推開公立醫院綜合改革工(gong)作的通知(zhi)。通知(zhi)要求,2017年全(quan)國公立醫院醫療(liao)費用平均(jun)增長幅度(du)控制在10%以下,9月30日前所有公立醫院全(quan)部(bu)(bu)取(qu)消藥品(pin)加成(中(zhong)藥飲片除(chu)外)。
通知指出(chu),全面推開城市公(gong)(gong)立(li)醫(yi)院綜合(he)改革。7月31日(ri)前(qian),所有地(di)(di)市出(chu)臺城市公(gong)(gong)立(li)醫(yi)院綜合(he)改革實(shi)施(shi)方案;國家衛計委、國家中醫(yi)藥局屬(管)醫(yi)院全部參加屬地(di)(di)公(gong)(gong)立(li)醫(yi)院綜合(he)改革。
通知要求(qiu),鞏固(gu)完善前(qian)4批(pi)試點(dian)城(cheng)市公(gong)立醫(yi)院綜合改革。到(dao)(dao)2017年(nian)年(nian)底,前(qian)4批(pi)試點(dian)城(cheng)市公(gong)立醫(yi)院藥占比(不含中(zhong)藥飲片)總體下降到(dao)(dao)30%左右;百元(yuan)醫(yi)療(liao)收入(不含藥品收入)中(zhong)消耗的衛生材(cai)料降到(dao)(dao)20元(yuan)以(yi)(yi)下;實行按病(bing)種(zhong)收付費的病(bing)種(zhong)不少(shao)于100個;預約轉診占公(gong)立醫(yi)院門診就診量(liang)的比例要提高到(dao)(dao)20%以(yi)(yi)上(shang);區域內所有二(er)級(ji)及以(yi)(yi)上(shang)公(gong)立醫(yi)院和80%以(yi)(yi)上(shang)的基(ji)層醫(yi)療(liao)衛生機構(gou)與(yu)區域人口健康(kang)信(xin)息平(ping)臺對(dui)接;60%的基(ji)層醫(yi)療(liao)衛生機構(gou)與(yu)上(shang)級(ji)醫(yi)院建立遠程(cheng)醫(yi)療(liao)信(xin)息系統。
通知指出,拓展(zhan)深化(hua)縣(xian)(xian)(xian)級(ji)(ji)公(gong)(gong)立(li)醫(yi)院(yuan)(yuan)綜(zong)合(he)改革(ge)。到2017年底,全面(mian)實行以按(an)病種付費(fei)為(wei)主,按(an)人頭付費(fei)、按(an)床(chuang)日付費(fei)等復合(he)型付費(fei)方式,探索符合(he)中醫(yi)藥特點的支付方式,鼓勵中醫(yi)藥服務提供和使用(yong);縣(xian)(xian)(xian)級(ji)(ji)公(gong)(gong)立(li)醫(yi)院(yuan)(yuan)門診(zhen)、住院(yuan)(yuan)患者人均費(fei)用(yong)和總收(shou)入(ru)增幅(fu)下降,醫(yi)療服務收(shou)入(ru)(不含(han)藥品、耗材(cai)、檢查、化(hua)驗收(shou)入(ru))占業(ye)務收(shou)入(ru)比(bi)(bi)重提升,自付醫(yi)療費(fei)用(yong)占總醫(yi)療費(fei)用(yong)比(bi)(bi)例(li)下降。同(tong)時,擴大公(gong)(gong)立(li)醫(yi)院(yuan)(yuan)綜(zong)合(he)改革(ge)示范(fan)。各省(sheng)(區)分別(bie)確定1個(ge)(ge)(ge)城(cheng)市(shi)(shi)(shi)(shi)(shi)作為(wei)省(sheng)級(ji)(ji)公(gong)(gong)立(li)醫(yi)院(yuan)(yuan)綜(zong)合(he)改革(ge)示范(fan)城(cheng)市(shi)(shi)(shi)(shi)(shi);各直轄市(shi)(shi)(shi)(shi)(shi)分別(bie)確定1個(ge)(ge)(ge)區(縣(xian)(xian)(xian))開(kai)展(zhan)省(sheng)級(ji)(ji)示范(fan)工作。除安徽(hui)、福建、江(jiang)蘇、青(qing)海4省(sheng)外,各省(sheng)(區)及兵(bing)團分別(bie)推薦1個(ge)(ge)(ge)縣(xian)(xian)(xian)(市(shi)(shi)(shi)(shi)(shi)、師(shi))作為(wei)第二批國(guo)(guo)家級(ji)(ji)示范(fan)候選縣(xian)(xian)(xian)(市(shi)(shi)(shi)(shi)(shi)、師(shi))。省(sheng)級(ji)(ji)示范(fan)城(cheng)市(shi)(shi)(shi)(shi)(shi)、國(guo)(guo)家級(ji)(ji)示范(fan)候選縣(xian)(xian)(xian)(市(shi)(shi)(shi)(shi)(shi)、師(shi))和直轄市(shi)(shi)(shi)(shi)(shi)示范(fan)縣(xian)(xian)(xian)(區)名(ming)單(dan)經省(sheng)級(ji)(ji)醫(yi)改領導(dao)小組同(tong)意(yi)后,于5月15日前報國(guo)(guo)務院(yuan)(yuan)醫(yi)改辦。
中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)聲(sheng)明(ming):凡本(ben)網(wang)(wang)(wang)注明(ming)“來(lai)源(yuan):中(zhong)(zhong)(zhong)(zhong)國(guo)證(zheng)(zheng)券(quan)(quan)報·中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)”的所有作(zuo)品(pin),版權均屬于中(zhong)(zhong)(zhong)(zhong)國(guo)證(zheng)(zheng)券(quan)(quan)報、中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)。中(zhong)(zhong)(zhong)(zhong)國(guo)證(zheng)(zheng)券(quan)(quan)報·中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)與作(zuo)品(pin)作(zuo)者(zhe)(zhe)聯合聲(sheng)明(ming),任(ren)何組織未(wei)經中(zhong)(zhong)(zhong)(zhong)國(guo)證(zheng)(zheng)券(quan)(quan)報、中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)以及作(zuo)者(zhe)(zhe)書(shu)面(mian)授(shou)權不(bu)得轉載(zai)、摘編或利(li)用其它(ta)(ta)方(fang)式使用上述作(zuo)品(pin)。凡本(ben)網(wang)(wang)(wang)注明(ming)來(lai)源(yuan)非中(zhong)(zhong)(zhong)(zhong)國(guo)證(zheng)(zheng)券(quan)(quan)報·中(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網(wang)(wang)(wang)的作(zuo)品(pin),均轉載(zai)自其它(ta)(ta)媒體(ti),轉載(zai)目的在于更好服務讀者(zhe)(zhe)、傳遞信(xin)息之需,并不(bu)代表(biao)本(ben)網(wang)(wang)(wang)贊同其觀點,本(ben)網(wang)(wang)(wang)亦(yi)不(bu)對其真實性負(fu)責,持異議者(zhe)(zhe)應(ying)與原出處單位主張權利(li)。
特別鏈接:政府部門交易機構證券期貨四所兩司新聞發布平臺友情鏈接版權聲明
關于報社關于本站廣告發布免責條款
中國證券報社版權所有,未經書面授權不得復制或建立鏡像 經營許可證編號:京B2-20180749 京公網安備0-1
Copyright 2001-2018 China Securities Journal. All Rights Reserved
中國(guo)證券報社版權所有,未經書面授(shou)權不得復制或建立鏡像
經營許可證編(bian)號:京B2-20180749 京公網(wang)安備0-1
Copyright 2001-2018 China Securities Journal. All Rights Reserved